Health
Full intensity heparin has value in treating hospitalized COVID-19 patients – News-Medical.Net
Results from the RAPID clinical trial suggest heparin may lower the risk of death from moderate COVID-19 infection by 78%. Heparin…
Heparin is typically administered for blood clotting, but its anti-inflammatory and anti-viral effects have captured interest as a potential COVID-19 treatment. An international team of researchers led by Peter Jüni of St. Michael’s Hospital and the University…
Continue Reading
-
Noosa News20 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General19 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
General22 hours agoMan dies at shopping centre car park at Charlestown following reports of assault
-
Noosa News22 hours agoWomen’s Softball World Cup 2027 Redcliffe Brisbane